Actively Recruiting
Communicating About Nicotine Reduction in Cigarettes
Led by Georgia State University · Updated on 2025-10-29
1230
Participants Needed
2
Research Sites
176 weeks
Total Duration
On this page
Sponsors
G
Georgia State University
Lead Sponsor
E
Emory University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavior and attitudes among adult smokers. The study also aims to assess the efficacy of the messages in different populations, including smokers with past-month serious psychological distress (SPD), low socioeconomic status (SES), and those in neither category. The primary hypothesis is: exposure to messages in combination with VLNC use will lead to less cigarettes use compared to VLNCs without messages. Researchers will compare: The effects of receiving VLNCs with messages (treatment group) to receiving VLNCs without messages (control group). Participants will: Complete a baseline survey and be randomly assigned to one of two groups: treatment (VLNCs + messages) or control (VLNCs only). Attend weekly study visits for surveys, breath samples, and receive supply of VLNCs , either with or without the messaging campaign. Complete brief daily surveys through text messages.
CONDITIONS
Official Title
Communicating About Nicotine Reduction in Cigarettes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 21+ years
- Current smoker having smoked 100 cigarettes in lifetime
- Smoking at least 27 days out of past 30 days
- Expired breath carbon monoxide level of 6 ppm or higher to confirm regular smoking
- Able to speak, read, and write English
- Available for the full study period
- Willing to try novel research cigarettes
You will not qualify if you...
- Pregnant or breastfeeding
- Living in the same household as another study participant
- Not willing to use research cigarettes during the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Georgia State university
Atlanta, Georgia, United States, 30303
Actively Recruiting
2
Emory University
Atlanta, Georgia, United States, 30322
Actively Recruiting
Research Team
L
Lyudmila Popova, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here